Mirela Sedić

1.5k total citations
49 papers, 1.3k citations indexed

About

Mirela Sedić is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mirela Sedić has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Organic Chemistry and 14 papers in Oncology. Recurrent topics in Mirela Sedić's work include Synthesis and biological activity (9 papers), Click Chemistry and Applications (7 papers) and Biochemical and Molecular Research (5 papers). Mirela Sedić is often cited by papers focused on Synthesis and biological activity (9 papers), Click Chemistry and Applications (7 papers) and Biochemical and Molecular Research (5 papers). Mirela Sedić collaborates with scholars based in Croatia, Switzerland and United Kingdom. Mirela Sedić's co-authors include Sandra Kraljević Pavelić, Krešimir Pavelić, Petra Grbčić, Silvana Raić‐Malić, Grace Karminski‐Zamola, Marijana Hranjec, Marijeta Kralj, Lidija Šuman, Ivo Piantanida and Anja Harej and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Mirela Sedić

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirela Sedić Croatia	18	705	514	136	111	58	49	1.3k
Guisen Zhao China	18	490 0.7×	537 1.0×	123 0.9×	67 0.6×	62 1.1×	58	1.1k
Qiang Ding China	21	442 0.6×	981 1.9×	172 1.3×	171 1.5×	31 0.5×	51	1.6k
Peter G. Goekjian France	24	1.0k 1.4×	907 1.8×	126 0.9×	39 0.4×	118 2.0×	65	1.7k
Karson S. Putt United States	21	254 0.4×	699 1.4×	413 3.0×	81 0.7×	57 1.0×	42	1.5k
Keizo Koya United States	19	406 0.6×	627 1.2×	205 1.5×	102 0.9×	27 0.5×	31	1.2k
Ramesh Ummanni India	25	494 0.7×	756 1.5×	167 1.2×	231 2.1×	57 1.0×	64	1.6k
Dan Mao China	19	285 0.4×	352 0.7×	79 0.6×	74 0.7×	49 0.8×	54	893
Matthew G. Bursavich United States	17	379 0.5×	504 1.0×	106 0.8×	76 0.7×	122 2.1×	29	904
Sang Min Lim South Korea	19	385 0.5×	948 1.8×	281 2.1×	68 0.6×	82 1.4×	50	1.5k
Wanjun Zheng United States	14	358 0.5×	281 0.5×	194 1.4×	65 0.6×	164 2.8×	19	907

Countries citing papers authored by Mirela Sedić

Since Specialization

Citations

This map shows the geographic impact of Mirela Sedić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirela Sedić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirela Sedić more than expected).

Fields of papers citing papers by Mirela Sedić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirela Sedić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirela Sedić. The network helps show where Mirela Sedić may publish in the future.

Co-authorship network of co-authors of Mirela Sedić

This figure shows the co-authorship network connecting the top 25 collaborators of Mirela Sedić. A scholar is included among the top collaborators of Mirela Sedić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirela Sedić. Mirela Sedić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dittmann, Antje, et al.. (2023). Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib. Biology. 12(4). 608–608. 2 indexed citations

Dittmann, Antje, Olga Vasieva, Luka Bočkor, et al.. (2023). Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. International Journal of Molecular Sciences. 24(16). 12906–12906. 1 indexed citations

Bistrović, Andrea, Petra Grbčić, Mirela Sedić, et al.. (2021). Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation. Molecules. 26(11). 3334–3334. 12 indexed citations

Grbčić, Petra, Marijana Raðić Stojković, Krešimir Pavelić, et al.. (2021). Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding. Molecules. 26(22). 7060–7060. 5 indexed citations

Grbčić, Petra, et al.. (2021). Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib. International Journal of Molecular Sciences. 22(12). 6174–6174. 11 indexed citations

Grbčić, Petra, Thomas O. Eichmann, Sandra Kraljević Pavelić, & Mirela Sedić. (2021). The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein. International Journal of Molecular Sciences. 22(19). 10767–10767. 10 indexed citations

Grbčić, Petra, et al.. (2018). Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling. Biochemical and Biophysical Research Communications. 503(2). 843–848. 21 indexed citations

Racanè, Livio, Mirela Sedić, Petra Grbčić, et al.. (2018). Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl)benzothiazole mesylates. Molecular Diversity. 22(3). 723–741. 18 indexed citations

Bistrović, Andrea, Luka Krstulović, Anja Harej, et al.. (2017). Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. European Journal of Medicinal Chemistry. 143. 1616–1634. 93 indexed citations

10.

Sedić, Mirela, et al.. (2016). Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(10). 1938–1954. 23 indexed citations

11.

Kraljević, Tatjana Gazivoda, Anja Harej, Mirela Sedić, et al.. (2016). Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole–coumarin hybrids. European Journal of Medicinal Chemistry. 124. 794–808. 124 indexed citations

12.

Pavelić, Sandra Kraljević, et al.. (2015). UV-induced retinal proteome changes in the rat model of age-related macular degeneration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(9). 1833–1845. 16 indexed citations

13.

Sedić, Mirela, Lee A. Gethings, Johannes P.C. Vissers, et al.. (2014). Label-free mass spectrometric profiling of urinary proteins and metabolites from paediatric idiopathic nephrotic syndrome. Biochemical and Biophysical Research Communications. 452(1). 21–26. 32 indexed citations

14.

Wittine, Karlo, Maja Babić, Damjan Makuc, et al.. (2012). Novel 1,2,4-triazole and imidazole derivatives of l-ascorbic and imino-ascorbic acid: Synthesis, anti-HCV and antitumor activity evaluations. Bioorganic & Medicinal Chemistry. 20(11). 3675–3685. 78 indexed citations

15.

Pavelić, Sandra Kraljević, et al.. (2011). Metastasis: new perspectives on an old problem. Molecular Cancer. 10(1). 22–22. 130 indexed citations

16.

Wittine, Karlo, Mario Cetina, Mirela Sedić, et al.. (2010). The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4′-benzamido-2′-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations. Bioorganic & Medicinal Chemistry. 18(17). 6249–6257. 5 indexed citations

17.

Horvatić, Anita, et al.. (2010). Differences between reversible (self-association) and irreversible aggregation of rHuG-CSF in carbohydrate and polyol formulations. European Journal of Pharmaceutics and Biopharmaceutics. 76(3). 357–365. 9 indexed citations

18.

Sedić, Mirela, Peter Gehrig, Mike Scott, et al.. (2008). Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2- α ]quinoline in colon cancer cells depending on their p53 status. Molecular Cancer Therapeutics. 7(7). 2121–2132. 39 indexed citations

19.

Stavljenić-Rukavina, Ana, Maurizio Ferrari, Laura Cremonesi, et al.. (2007). The 7th EFCC Continuous Postgraduate Course in Clinical Chemistry: New trends in diagnosis, monitoring and management using molecular diagnosis methods. 1 indexed citations

20.

Kralj, Marijeta, Sandra Kraljević Pavelić, Mirela Sedić, Asim Kurjak, & Krešimir Pavelić. (2005). Global approach to perinatal medicine: functional genomics and proteomics. Journal of Perinatal Medicine. 33(1). 5–16. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact